Butalbital, Aspirin, and Caffeine Capsules, USP is supplied in capsule form for oral administration.
Each capsule contains the following active ingredients:
| butalbital, USP. .. .. .. .. .. ..
| aspirin, USP.. .. .. .. .. .. .. ..
| caffeine, USP. .. .. .. .. .. .. .
Butalbital, Aspirin, and Caffeine Capsules, USP is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Butalbital, Aspirin, and Caffeine Capsules, USP in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.
Media Articles Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)
Source: MedicineNet Anthrax Specialty [2015.11.13]
Category: Diseases and Conditions
Created: 5/31/2002 12:00:00 AM
Last Editorial Review: 11/13/2015 12:00:00 AM
Source: MedicineNet Allergy Specialty [2015.10.30]
Title: Sinus Headache
Category: Diseases and Conditions
Created: 1/11/2010 12:00:00 AM
Last Editorial Review: 10/30/2015 12:00:00 AM
Severe Headache During Pregnancy May Signal Trouble
Source: MedicineNet Pregnancy Induced Hypertension Specialty [2015.08.21]
Title: Severe Headache During Pregnancy May Signal Trouble
Category: Health News
Created: 8/20/2015 12:00:00 AM
Last Editorial Review: 8/21/2015 12:00:00 AM
Severe headache in pregnant women: When to worry
Source: Headache / Migraine News From Medical News Today [2015.08.20]
New findings by Montefiore and Einstein researchers offer first clinical recommendationsIf a pregnant woman with high blood pressure and no history of headache suddenly develops a headache that...
More evidence that kids' headaches increase at back-to-school time
Source: Headache / Migraine News From Medical News Today [2015.08.17]
Findings from Nationwide Children's Hospital physicians demonstrate that headaches increase in fall in children, a trend that may be due to back-to-school changes in stress, routines and sleep.
Published Studies Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)
Butalbital in the treatment of headache: history, pharmacology, and efficacy. [2001.11]
Analgesics containing butalbital compounded with aspirin, acetaminophen, and/or caffeine are widely used for the treatment of migraine and tension-type headache. The butalbital-containing compounds are efficacious in placebo-controlled trials among patients with episodic tension-type headaches.Because of concerns about overuse, medication-overuse headache, and withdrawal, their use should be limited and carefully monitored.
A protocol for butalbital, aspirin and caffeine (BAC) detoxification in headache patients. [1990.07]
The abuse of the combination drug containing butalbital 50 mg, aspirin 325 mg and caffeine 40 mg (or BAC), is commonly recognized by headache specialists as causing headaches. Despite this widespread problem, there is not a published treatment regimen for the BAC detoxification of patients.The other two patients were still BAC free 18 and 14 months after detoxification.
Clinical Trials Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)
Metabolomic Fingerprint After Bariatric Surgery [Completed]
Background: Obesity is associated with multiple diseases. Bariatric surgery is the most
effective therapy for severe obesity that cannot only reduce body weight but also
Objective: The metabolic alterations associated with obesity and respective changes after
bariatric surgery are incompletely understood.
Design: In the longitudinal observational study, the investigator applied a 1H-NMR-based
global, untargeted metabolomics strategy on human serum samples that were collected before
and repeatedly up to one year after distinct bariatric procedures (sleeve gastrectomy,
proximal and distal Roux-en Y gastric bypass; RYGB). For comparison, the investigator also
analyzed serum samples from normal-weight and less obesity obese subjects that were matched
for 1-year postoperative BMI values of the surgical groups.
Page last updated: 2015-11-13